BioCentury | Feb 13, 2012
Emerging Company Profile

Abide: Selecting serine hydrolases

...CEO: Alan Ezekowitz Patents: 10 issued covering MAGL , FAAH , arylacetamide deacetylase-like 1 ( AADACL1 ; KIAA1363...
BioCentury | May 5, 2011
Distillery Therapeutics

Indication: Cancer

...Prostate cancer Arylacetamide deacetylase-like 1 (AADACL1; KIAA1363) An in vitro and mouse study identified an inhibitor of KIAA1363...
...prostate cancer. In a prostate cancer cell line, the lead O-aryl carbamate inhibitor JW480 blocked KIAA1363...
...plus other agents in models of prostate cancer metastasis and in other cancers that show KIAA1363...
BioCentury | Aug 5, 2002
Company News

ActivX other research news

...set of secreted and membrane-associated enzyme activities were up-regulated, including urokinase and the membrane-associated hydrolase KIAA1363...
Items per page:
1 - 3 of 3